Drug intelligence / Profile preview

etodolac

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and symptoms of arthritis, including osteoarthritis and rheumatoid arthritis. It works by inhibiting cyclooxygenase (COX) enzymes, particularly showing preferential selectivity for COX-2 over COX-1, which leads to reduced synthesis of prostaglandins involved in inflammation, pain, and fever. Etodolac has analgesic and antipyretic properties but does not cure underlying disease; it only manages symptoms as long as therapy continues. The drug was patented in 1971 and approved for medical use in 1985. Developed by Wyeth.

Brand names
LodineLodine XL
Other names
etodolac
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on etodolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on etodolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call